Lisinopril vs. Losartan: Differential Effects on Urinary Sodium Excretion
Lisinopril (ACE inhibitor) increases urinary sodium excretion; losartan (ARB) does not significantly.
Mechanistic Basis
- ACEi (lisinopril): Blocks Ang I → Ang II conversion → ↓ Ang II + ↑ bradykinin.
- ↓ Ang II → ↓ aldosterone → ↓ distal Na⁺ reabsorption (ENaC).
- ↑ Bradykinin → ↑ NO/prostanoids → ↑ renal blood flow, ↓ proximal reabsorption.
- Net: Natriuresis, especially with volume expansion/heart failure.
- ARB (losartan): Blocks AT₁ receptor only.
- ↑ Ang II levels (unopposed AT₂ stimulation → vasodilation, natriuresis? — weak in humans).
- No bradykinin accumulation.
- Net: Minimal acute natriuresis; chronic Na⁺ balance via hemodynamic effects.
Clinical Implications
- ACEi preferred in heart failure with volume overload (natriuretic synergy with loop diuretics).
- ARB alternative if ACEi cough/angioedema; similar BP/renal outcomes.
- Both require K⁺/Cr monitoring (hyperkalemia risk, especially with K⁺-sparing agents).
Evidence
Multiple trials (SOLVD, ATLAS, RENAAL, IDNT) confirm ACEi natriuretic effect; ARBs show less pronounced acute sodium excretion.
Urinary Disorders - Related Articles
- Urge Incontinence: Medications & Treatment Options
- Female Urethra: Anatomy, Function, and Key Differences from Male Urethra
- Understanding and Treating Bladder Infections (Cystitis) in Adults
- Freedom Catheter: Understanding & Using External Catheters for Men
- Understanding and Managing Bladder Spasms: Causes & Relief
- Lisinopril vs. Losartan: Differential Effects on Urinary Sodium Excretion
- Vesicare (Solifenacin): Uses, Symptoms & Treatment
